GMO Product Platform Inc
GMO Product Platform Inc provides advertising and marketing services, primarily generating revenue through the delivery of digital and traditional marketing solutions to clients in Japan and internationally.
Business. GMO Product Platform Inc (3695.T) is a Japanese advertising and marketing company headquartered in Japan. The firm operates within the Cyclical Consumer Services sector, focusing on advertising and marketing activities. It is primarily listed on the Tokyo Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
GMO Product Platform Inc (3695.T) is a Japanese advertising and marketing company headquartered in Japan. The firm operates within the Cyclical Consumer Services sector, focusing on advertising and marketing activities. It is primarily listed on the Tokyo Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not available.
GMO Product Platform Inc maintains a strong liquidity position, with a current ratio of 2.35, indicating that the company has more than twice the current assets to cover its current liabilities. The company's cash and equivalents amount to 876.26 million JPY, which is a significant portion of its total assets of 3,045.43 million JPY. The company's debt-to-equity ratio is 0.0, suggesting that it is not leveraged and relies primarily on equity financing.
In terms of profitability, GMO Product Platform Inc reports a return on equity (ROE) of 4.67% and a return on assets (ROA) of 3.03%. These figures are below the industry median for ROE and ROA in the Advertising & Marketing sector, indicating that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks, particularly in the event of a downturn in the advertising and marketing industry.
Looking ahead, GMO Product Platform Inc is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the current or next fiscal year. The company's recent revenue of 13.62 billion JPY aligns with the analyst estimate of 6.82 billion JPY for the most recent quarter, suggesting a consistent performance in the short term.
The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based flags detected. The absence of long-term debt and the high level of cash reserves further support the company's strong liquidity position. However, the company's reliance on a single business model and lack of diversification could pose long-term risks if market conditions change.
Recent filings and transcripts do not indicate any material events or strategic shifts for GMO Product Platform Inc. The company's financial performance and operational strategy appear to be stable, with no significant changes in its business model or capital structure reported in the latest disclosures.
- GMO Product Platform Inc has a strong liquidity position with a current ratio of 2.35 and no long-term debt.
- The company's ROE and ROA are below the industry median, indicating underperformance in capital efficiency and asset utilization.
- Revenue is concentrated in a single business segment, with no material geographic diversification reported.
- The company is expected to maintain a stable revenue trajectory with no significant growth or decline projected.
- Low liquidity and dilution risks are reported, with no immediate filing-based flags detected.
Bull / Bear case
Generated · model-assistedRevenue surged 35.7% year-over-year to JPY 6.8 billion, demonstrating strong top-line growth momentum.
Free cash flow rebounded sharply by 899.6% to JPY 93.5 million, indicating improved cash generation.
Net income CAGR of -13.2% over four years indicates a persistent long-term earnings deterioration trend.
Long-term debt skyrocketed to JPY 650.2 million, a massive increase from JPY 5.5 million prior year.
Return on assets of 3.0% remains modest, suggesting limited efficiency in asset deployment despite revenue growth.
In focus — financials by report
Revenue ¥1.90B, +38,9% YoY; Operating income −65,6% YoY.
- ▍Revenue ¥1.90B, +38,9% YoY
- ▍Operating income −65,6% YoY
- ▍Net income −52,1% YoY
- ▍Net margin 3.1%
Revenue ¥1.75B, +46,6% YoY; Operating income +5 075,9% YoY.
- ▍Revenue ¥1.75B, +46,6% YoY
- ▍Operating income +5 075,9% YoY
- ▍Net income +884,1% YoY
- ▍Net margin 6.1%
Revenue ¥1.85B, +67,8% YoY; Operating income +442,3% YoY.
- ▍Revenue ¥1.85B, +67,8% YoY
- ▍Operating income +442,3% YoY
- ▍Net income +377,1% YoY
- ▍Net margin 3.0%
Revenue ¥1.32B, −3,2% YoY; Operating income −175,1% YoY.
- ▍Revenue ¥1.32B, −3,2% YoY
- ▍Operating income −175,1% YoY
- ▍Net income −172,7% YoY
- ▍Net margin -5.1%
Revenue ¥1.37B; Operating income ¥161.5M.
- ▍Revenue ¥1.37B
- ▍Operating income ¥161.5M
- ▍Net margin 9.1%
Revenue ¥1.19B; Operating income ¥3.1M.
- ▍Revenue ¥1.19B
- ▍Operating income ¥3.1M
- ▍Net margin -1.1%
Revenue ¥1.10B; Operating income -¥49.1M.
- ▍Revenue ¥1.10B
- ▍Operating income -¥49.1M
- ▍Net margin -1.8%
Revenue ¥1.36B; Operating income ¥119.7M.
- ▍Revenue ¥1.36B
- ▍Operating income ¥119.7M
- ▍Net margin 6.8%
Revenue ¥6.82B, +35,7% YoY; Operating income +25,0% YoY.
- ▍Revenue ¥6.82B, +35,7% YoY
- ▍Operating income +25,0% YoY
- ▍Net income −15,0% YoY
- ▍Free cash flow +899,6% YoY
- ▍Net margin 2.3%
Revenue ¥5.03B, −1,8% YoY; Operating income −45,6% YoY.
- ▍Revenue ¥5.03B, −1,8% YoY
- ▍Operating income −45,6% YoY
- ▍Net income −40,4% YoY
- ▍Free cash flow −112,0% YoY
- ▍Net margin 3.6%
Revenue ¥5.12B, −1,6% YoY; Operating income +3,0% YoY.
- ▍Revenue ¥5.12B, −1,6% YoY
- ▍Operating income +3,0% YoY
- ▍Net income −13,8% YoY
- ▍Free cash flow −54,1% YoY
- ▍Net margin 6.0%
Revenue ¥5.20B, +27,3% YoY; Operating income +19,0% YoY.
- ▍Revenue ¥5.20B, +27,3% YoY
- ▍Operating income +19,0% YoY
- ▍Net income +30,0% YoY
- ▍Free cash flow +18,5% YoY
- ▍Net margin 6.9%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Assetsnet_income / total_assets
- GMO Product Platform Inc Market data — financials · 2026-05-26
- GMO Product Platform Inc Market data — analyst estimates · 2026-05-26